Artículo - Echosens

Elija su ubicación

Elija su idioma

Statement on the acceptance by the FDA of Echosens’ Letter of Intent for Drug Development Tool (DDT)

A New Era for Liver Care: Prof. Dr. Jörn Schattenberg on the EC Approval of Rezdiffra™ for MASH

A call for doubling the diagnostic rate of at-risk MASH

New publication on our new technology Guided VCTE™

Declaración de Echosens sobre el fallecimiento del Dr. Stephen Harrison

Join us on World Liver Day 2024

Liver Health Experts and Echosens Technology Featured on eHealth Radio Network

Highlights from 2021 AASLD Liver Meeting: Early Detection and Monitoring with FibroScan^® Mitigates Risk of Patients Developing Fibrosis/Cirrhosis

Non-Invasive Point-of-Care Exam Helps Battle Liver Disease in Individuals with Obesity

Link Between Non-alcoholic Fatty Liver Disease, Obesity and Liver Cancer Calls for Early Detection and Monitoring

1
2
3
Suivant

URL
Este campo es un campo de validación y debe quedar sin cambios.
País*
Su e-mail*
Al suscribirme, acepto que Echosens recopile y utilice mis datos de conformidad con la Política de privacidad